SPIE SA (EPA:SPIE)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,420	5,074	4,711	3,969	3,696	2,809
Market Cap Growth	42.19%	7.70%	18.71%	7.39%	31.58%	-1.93%
Enterprise Value	11,051	7,596	6,454	5,861	5,425	4,620
Last Close Price	50.10	29.52	27.16	22.76	20.60	15.69
PE Ratio	41.47	18.57	19.75	26.19	21.85	52.78
Forward PE	16.83	10.86	12.46	12.56	13.40	13.44
PS Ratio	0.81	0.51	0.53	0.48	0.52	0.42
PB Ratio	4.38	2.42	2.38	2.09	2.20	1.82
P/FCF Ratio	8.66	6.10	7.23	7.76	8.23	5.68
P/OCF Ratio	8.01	5.51	6.60	6.87	7.16	5.01
PEG Ratio	1.20	0.75	0.96	1.01	0.62	4.54
EV/Sales Ratio	1.07	0.76	0.73	0.72	0.77	0.69
EV/EBITDA Ratio	11.10	9.19	9.50	9.36	10.20	10.78
EV/EBIT Ratio	16.15	11.88	11.94	11.94	13.36	14.44
EV/FCF Ratio	11.37	9.13	9.90	11.46	12.08	9.34
Debt / Equity Ratio	1.52	1.35	1.30	1.39	1.51	1.63
Debt / EBITDA Ratio	2.94	2.80	3.07	3.40	3.80	4.44
Debt / FCF Ratio	3.01	3.41	3.93	5.15	5.67	5.07
Asset Turnover	1.05	1.05	0.98	0.94	0.84	0.81
Inventory Turnover	182.27	190.16	152.28	152.90	167.22	162.05
Quick Ratio	0.64	0.68	0.81	0.84	0.84	0.84
Current Ratio	0.77	0.79	0.92	0.95	0.96	0.95
Return on Equity (ROE)	10.66%	13.49%	12.36%	8.61%	10.57%	3.60%
Return on Assets (ROA)	4.34%	4.18%	3.74%	3.50%	3.01%	2.41%
Return on Capital (ROIC)	8.79%	8.43%	7.46%	7.01%	6.13%	5.01%
Return on Capital Employed (ROCE)	12.30%	11.50%	10.70%	9.80%	8.10%	6.60%
Earnings Yield	2.41%	5.38%	5.06%	3.82%	4.58%	1.90%
FCF Yield	11.54%	16.40%	13.83%	12.89%	12.15%	17.61%
Dividend Yield	1.94%	3.39%	3.06%	3.21%	2.91%	2.80%
Payout Ratio	82.63%	52.54%	53.13%	69.88%	53.98%	-
Buyback Yield / Dilution	-	-1.69%	-1.01%	-1.65%	-1.95%	-1.33%
Total Shareholder Return	1.94%	1.69%	2.04%	1.56%	0.97%	1.47%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.